buthionine sulfoximine has been researched along with Adenoma Sebaceum in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aronica, E; Borkowska, J; Grajkowska, W; Iyer, AM; Jaworski, J; Jozwiak, S; Kotulska, K; Kwiatkowski, DJ; Liszewska, E; Macias, M; Malik, AR; Parobczak, K; Perycz, M; Pietruszka, P; Skalecka, A; Swiech, LJ; Tyburczy, ME; Urbanska, M; Zarebska, MM | 1 |
1 other study(ies) available for buthionine sulfoximine and Adenoma Sebaceum
Article | Year |
---|---|
Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.
Topics: Adolescent; Animals; Brain; Buthionine Sulfoximine; Cell Proliferation; Child; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Female; Glutamate-Cysteine Ligase; Green Fluorescent Proteins; Humans; Immunosuppressive Agents; Male; Neurons; RNA, Small Interfering; Sirolimus; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Young Adult | 2015 |